Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

930 indexed citations

Abstract

loading...

About

This paper, published in 1998, received 930 indexed citations. Written by Lisa Park, Kathleen G. Raman, Yan Lü, Luis Ferran, Wing Chow, David M. Stern and Ann Marie Schmidt covering the research area of Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. It is primarily cited by scholars working on Clinical Biochemistry (746 citations), Endocrinology, Diabetes and Metabolism (376 citations) and Molecular Biology (187 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/2012 →

Countries where authors are citing Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

Specialization
Citations

This map shows the geographic impact of Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts more than expected).

Fields of papers citing Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/2012.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026